Praxis Precision Medicines (PRAX) Cash from Investing Activities Growth (3y) (2024 - 2026)

Praxis Precision Medicines (PRAX) Cash from Investing Activities Growth (3y) (2024 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash from Investing Growth (3y) (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	46.78%
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	66.14%
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-39.73%
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	296.32%
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-53.57%
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-246.81%
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	27.84%
10	Praxis Precision Medicines	10.24 Bn	9.48 Bn	-	29.99%

Download Data